Farmak’s Acquisition of Symphar

DLA Piper has advised the shareholders of Symphar sp. z o.o. on the deal. Symphar sp. z o.o., a leading Polish pharmaceutical business, announced the sale...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here